Safety and immunogenicity of a five-component acellular pertussis vaccine with varying antigen quantities
SA Halperin, L Barreto, BJ Eastwood… - … of pediatrics & …, 1994 - jamanetwork.com
… No in¬ creased adverse effects were demonstrated with in¬ creased antigen content in the
acellular vaccine formu¬ lations. The APV formulation is currently part of the second efficacy …
acellular vaccine formu¬ lations. The APV formulation is currently part of the second efficacy …
Cell-mediated and antibody responses to Bordetella pertussis antigens in children vaccinated with acellular or whole-cell pertussis vaccines
A Cassone, CM Ausiello, F Urbani… - … of pediatrics & …, 1997 - jamanetwork.com
… B pertussis antigens (pertussis toxin, filamentous hemagglutinin, and pertactin). Antibody titers
against pertussis … Results: A CMI-positive response to at least 1 B pertussis antigen at 1 or …
against pertussis … Results: A CMI-positive response to at least 1 B pertussis antigen at 1 or …
Decennial administration of a reduced antigen content diphtheria and tetanus toxoids and acellular pertussis vaccine in young adults
J Mertsola, O Van Der Meeren, Q He… - Clinical infectious …, 2010 - academic.oup.com
… populations against pertussis is generally achieved through administration of a single dose
of reduced antigen content combined diphtheria and tetanus toxoids and acellular pertussis (…
of reduced antigen content combined diphtheria and tetanus toxoids and acellular pertussis (…
Development of acellular pertussis vaccines
Y Sato, H Sato - Biologicals, 1999 - Elsevier
… that PTd was the essential antigen in the acellular pertussis vaccine but that fFHA … content
in the vaccine may be reduced by adding fFHA to get the same ED50, but total protein content …
in the vaccine may be reduced by adding fFHA to get the same ED50, but total protein content …
Outer membrane vesicles as acellular vaccine against pertussis
… immunogens in OMVs together with a variety of putatively important antigens. The structure
… antigens, each of which may be insufficient to confer immunity when administered alone. …
… antigens, each of which may be insufficient to confer immunity when administered alone. …
Immunogenicity and reactogenicity of acellular pertussis booster vaccines in children: standard pediatric versus a reduced-antigen content formulation
CU Meyer, P Habermehl, M Knuf, B Hoet… - Human …, 2008 - Taylor & Francis
… reduced antigen content diphtheria-tetanus-acellular pertussis vaccine (dTpa) administered
as a booster to 4-6 year-old children primed with four doses of whole-cell pertussis vaccine. …
as a booster to 4-6 year-old children primed with four doses of whole-cell pertussis vaccine. …
A decennial booster dose of reduced antigen content diphtheria, tetanus, acellular pertussis vaccine (Boostrix™) is immunogenic and well tolerated in adults
R Booy, O Van Der Meeren, SP Ng, F Celzo… - Vaccine, 2010 - Elsevier
… To our knowledge, this is the first study exploring the feasibility of repeated decennial booster
vaccination with reduced-antigen-content acellular pertussis vaccines in adults. The adults …
vaccination with reduced-antigen-content acellular pertussis vaccines in adults. The adults …
Dose-response to acellular pertussis vaccine and comparison with whole cell pertussis vaccine at 15–24 months and 4–6 years of age
…, NA Halsey, Acellular Pertussis Vaccine Study team - Vaccine, 1992 - Elsevier
… In order to address the issue of optimal antigen content of acellular pertussis … acellular DTP
vaccine in two dosage regimens in children 15-24 months and 4-6 years of age. The acellular …
vaccine in two dosage regimens in children 15-24 months and 4-6 years of age. The acellular …
Overview of recent clinical trials of acellular pertussis vaccines
E Miller - Biologicals, 1999 - Elsevier
… #icacy of acellular pertussis vaccines. The reactogenicity and immunogenicity results of the
various Phase II trials in which acellular vaccines with widely di#erent antigen contents have …
various Phase II trials in which acellular vaccines with widely di#erent antigen contents have …
High levels of antibody in adults three years after vaccination with a reduced antigen content diphtheria-tetanus-acellular pertussis vaccine
PB McIntyre, FM Turnbull, AM Egan, MA Burgess… - Vaccine, 2004 - Elsevier
… reactogenicity of whole-cell pertussis vaccines when administered beyond childhood. …
acellular pertussis vaccines with reduced antigen content has seen calls for widespread pertussis …
acellular pertussis vaccines with reduced antigen content has seen calls for widespread pertussis …
相关搜索
- acellular pertussis vaccine
- diphtheria tetanus antigen content
- booster vaccination of adults antigen content
- persistence of antibodies combined acellular pertussis
- acellular pertussis vaccination
- 20 month acellular pertussis vaccine booster
- reduced antigen content diphtheria pertussis vaccine
- dtpa ipv antigen content
- four trials antigen content
- high levels of antibody antigen content
- primary vaccination of adults antigen content
- booster vaccination of adults acellular pertussis
- reduced antigen content diphtheria tetanus toxoids
- dtpa vaccine antigen content